实用医学杂志Issue(19)：3241-3244,4.DOI:10.3969/j.issn.1006-5725.2015.19.040
右美托咪定复合舒芬太尼用于喉癌患者术后静脉镇痛效果评价
Evaluation of dexmedetomidine combining with sufentanyl for vein analgesia after laryngeal carcinoma surgery
叶兰 1陈冰宇 1田立刚 1尚宇1
作者信息
- 1. 110042 沈阳市，解放军第四六三医院麻醉科
- 折叠
摘要
Abstract
Objective To investigate the effectiveness and safety of dexmedetomidine combining with sufentanyl in controlling PCIA after laryngeal carcinoma surgery. Methods One hundred laryngeal carcinoma patients (ASAⅠorⅡ) were randomly assigned into 2 groups (n = 50, in each group). Group SF: sufentanil 0.04 mg/(kg·h)+dolasetron 12.5 mg; Group DE: dexmedetomidine 0.1 mg/(kg·h) +sufentani 0.02 mg/(kg· h) +dolasetron 12.5 mg, in which all drugs were dissolved in 100 mL 0.9% normal saline. Parameters: Infusion speed 2 mL/h; PCIA dosage 0.5 mL each time; monitor time: 15 min. PCIA were administrated after anesthesia recovery; BP, HR, SpO2, RR, RPP, pain and sedation score, side effect formation rate at 4、12、24、48 h after surgery were also recorded. Results MAP, RPP and HR in group DE were significant decreased compared with group SF at each time point,(P < 0.05); VAS scores had no significant difference between the two groups(P >0.05); Ramsay calm scores in group DE were significant better than that in group SF at each time point after surgery (P < 0.05); Frequency of nausea,vomiting and chills in group DE were significant lower than those in group SF (P < 0.05). Conclusion Small dose dexmedetomidine combination with sufentanil administration in PCIA after laryngeal carcinoma surgery could acquire satisfied analgesic effect , also could eliminate the patient anxious mood , enhance the security in the perioperative period and improve the patients' satisfaction degree , whichis very suitable for multi mode analgesia acquirement.关键词
右美托咪定/舒芬太尼/自控静脉镇痛/喉癌手术Key words
Dexmedetomidine/Sufentanil/PCIA/Laryngeal carcinoma surgery引用本文复制引用
叶兰,陈冰宇,田立刚,尚宇..右美托咪定复合舒芬太尼用于喉癌患者术后静脉镇痛效果评价[J].实用医学杂志,2015,(19):3241-3244,4.
